Stephen Yarbrough
Family Medicine · Moultrie, GANPI 1659934438
Payments from drug & device makers
Across 234 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$444
- Novo Nordisk$376
- AbbVie$374
- Lilly USA, LLC$337
- Pfizer$313
- Dexcom, Inc.$287
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 21 | $444 |
| Novo Nordisk | 21 | $376 |
| AbbVie | 16 | $374 |
| Lilly USA, LLC | 24 | $337 |
| Pfizer | 18 | $313 |
| Dexcom, Inc. | 20 | $287 |
| AstraZeneca | 12 | $260 |
| Bayer | 9 | $242 |
| GSK | 14 | $238 |
| Organogenesis Inc. | 2 | $169 |
| Otsuka America Pharmaceutical, Inc. | 8 | $156 |
| Corium, LLC | 7 | $139 |
| Boehringer Ingelheim | 6 | $124 |
| Astellas Pharma US Inc | 5 | $102 |
| Merck | 6 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $94 |
| Paratek Pharmaceuticals, Inc. | 2 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $83 |
| Exact Sciences | 5 | $81 |
| Sanofi Pasteur Inc. | 4 | $63 |
| Shield Therapeutics Inc | 3 | $58 |
| Ironshore Pharmaceuticals Inc. | 3 | $57 |
| Ardelyx, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Averitas Pharma Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURAPLY WOUND MATRIX$150
- EVENITY$123
- VRAYLAR$123
How this compares
$4,470 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 214 | $244,543 |
| JardianceEmpagliflozin | 88 | $74,308 |
| EliquisApixaban | 28 | $27,503 |
| OzempicSemaglutide | 17 | $21,565 |
| FarxigaDapagliflozin Propanediol | 25 | $21,416 |
| RybelsusSemaglutide | 22 | $20,534 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $11,976 |
| TradjentaLinagliptin | 16 | $11,706 |
| JanuviaSitagliptin Phosphate | 14 | $11,379 |
| LinzessLinaclotide | 12 | $9,732 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,608 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,379 |
| Gabapentin | 189 | $3,421 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $3,215 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 12 | $1,972 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $337 | $244,543214 claims |
| Boehringer IngelheimJardiance, Tradjenta | $124 | $86,014104 claims |
| Novo NordiskOzempic, Rybelsus | $376 | $42,10039 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $260 | $30,02438 claims |
| PfizerEliquis | $313 | $27,50328 claims |
| GSKTrelegy Ellipta | $238 | $11,97619 claims |
| MerckJanuvia | $96 | $11,37914 claims |
| AbbVieLinzess | $374 | $9,73212 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $19 | $5,37911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Moultrie
- Gary SwartzentruberMoultrie$38K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.